With head offices in Bonn, Germany, GENOPATH GbR is an association of 16 pathology institutes. The group formed to supply all member laboratories with top-quality and cutting-edge molecular diagnostic services that complement existing histological and cytological methods, making the comprehensive care available to every cancer patient.
“GENOPATH wishes to offer all patients in our care the most modern and comprehensive methods in molecular pathology possible. With the MH Guide software, we now have automated interpretation of extensive tumor genetic data at our disposal. We look forward to working together with Molecular Health.”
Dr. Christoph Schmitt,
Laboratory Director at GENOPATH
Challenge
The 16 laboratories of GENOPATH sought to harmonize the molecular pathology evaluations underpinning the care of cancer patients within their respective regions. A key issue was to ensure that the laboratories nevertheless had a broad menu of molecular tests to choose from.
Solution
The GENOPATH molecular laboratory performs a broad spectrum of tumor panels from different suppliers. Especially in the analysis of complex workups, as is often the case with multi-gene panels like the TSO500, output data are interpreted with MH Guide. Thus, the oncologist network supported by GENOPATH receives a standardized and comprehensive interpretation of molecular tumor data and information about therapy options.
Patient benefit
With up-to-date, comprehensive annotation of variants, each case evaluated by GENOPATH member laboratories results in an evidence-based decision about care for a patient. MH Guide enables harmonized data interpretation across laboratories and tests. Thus, the resulting reports are the basis for interactive discussions in the molecular tumor board to identify the best possible treatment, be it a targeted therapy or possibly participation in a clinical trial.
The OncoNet Rhein-Main is a network of clinics, molecular pathology laboratories, practices and medical centers that aims to provide effective and targeted care to all cancer patients in the Rhein-Main area. Working together, partners in the network support clinical studies to integrate innovative therapy approaches into daily clinical practice.
The Institute of Pathology at the Charité Berlin is a key player in the care of cancer patients of the country’s capital and surrounding area. Their broad spectrum of analytical methods covers histological, cytological, and molecular diagnostics to deliver the reliable and timely identification of therapeutic options.
Gen Era Diagnostics is a leading provider of molecular diagnostics products and services in Turkey. The company has empowered scientists, clinicians, and laboratories in the investigation of diseases and the treatment of patients since 2013 with a comprehensive offering of cutting-edge research and diagnostic technologies.
© 2020 Molecular Health GmbH
© 2021 Molecular Health GmbH
© 2020 Molecular Health GmbH
